Use of Motion Capture Technology to Study Extrinsic Laryngeal Muscle Tension and Hyperfunction
The Laryngoscope · 2023-12 · 133 (12) · 3472-3481
DOI: 10.1002/lary.30829 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 16.06.2023. Verfasst von Steven Hogue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, Erik Jonsson School of Engineering and Computer Science, University of Texas at Dallas, Richardson, Texas, USA. Hauptthemen laut MEDLINE: Laryngeal Muscles, Dysphonia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCD NIH HHS, National Science Foundation, National Institute on Deafness and Other Communication Disorders.
Abstract (Originalsprache)
Objectives
Patients with primary muscle tension dysphonia (pMTD) commonly report paralaryngeal pain and discomfort, and extrinsic laryngeal muscle (ELM) tension and hyperfunction are commonly implicated. However, quantitative physiological metrics to study ELM movement patterns for the characterization of pMTD diagnosis and monitoring of treatment progress are lacking. The objectives of this study were to validate motion capture (MoCap) technology to study ELM kinematics, determine whether MoCap could distinguish ELM tension and hyperfunction between individuals with and without pMTD, and investigate relationships between common clinical voice metrics and ELM kinematics.
Methods
Thirty subjects (15 with pMTD and 15 controls) were recruited for the study. Sixteen markers were placed on different anatomical landmarks on the chin and anterior neck. Movements across these regions were tracked during four voice and speech tasks using two three‐dimensional cameras. Movement displacement and variability were determined based on 16 key‐points and 53 edges.
Results
Intraclass correlation coefficients demonstrated high intra‐ and inter‐rater reliability ( p 's < 0.001). Other than greater movement displacements around the thyrohyoid space during longer phrasing (reading passage, 30‐s diadochokinetics) and more movement variability in patients with pMTD, kinematic patterns between groups were similar across the 53 edges for the four voice and speech tasks. There were also no significant correlations between ELM kinematics and standard voice metrics.
Conclusion
Results demonstrate the feasibility and reliability of MoCap for the study of ELM kinematics. Level of Evidence 3 Laryngoscope , 133:3472–3481, 2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Computer Science, Erik Jonsson School of Engineering and Computer Science, University of Texas at Dallas, Richardson, Texas, USA.
- Department of Speech, Language, and Hearing, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, Texas, USA.
- Department of Otolaryngology-Head and Neck, Voice Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
ORCID-Profile: Adrianna C Shembel
Förderung
- NIDCD NIH HHS
- National Science Foundation
- National Institute on Deafness and Other Communication Disorders
Zitieren
APA
Hogue, S., Guo, X., Morrison, R. A., McDowell, S., & Shembel, A. C. (2023). Use of Motion Capture Technology to Study Extrinsic Laryngeal Muscle Tension and Hyperfunction. The Laryngoscope, 133(12), 3472-3481. https://doi.org/10.1002/lary.30829
Vancouver
Hogue S, Guo X, Morrison RA, McDowell S, Shembel AC. Use of Motion Capture Technology to Study Extrinsic Laryngeal Muscle Tension and Hyperfunction. The Laryngoscope. 2023;133(12):3472-3481. doi:10.1002/lary.30829
BibTeX
@article{Hogue2023,
author = {Hogue, Steven and Guo, Xiaohu and Morrison, Robert A and McDowell, Sarah and Shembel, Adrianna C},
title = {Use of Motion Capture Technology to Study Extrinsic Laryngeal Muscle Tension and Hyperfunction},
journal = {The Laryngoscope},
year = {2023},
volume = {133},
number = {12},
pages = {3472--3481},
doi = {10.1002/lary.30829}
}
EUVIMED